Invention Grant
- Patent Title: Treatment of demyelinating disorders
-
Application No.: US14773088Application Date: 2014-03-05
-
Publication No.: US10905663B2Publication Date: 2021-02-02
- Inventor: Sharon Way , Benjamin Clayton , Brian Popko
- Applicant: THE UNIVERSITY OF CHICAGO
- Applicant Address: US IL Chicago
- Assignee: THE UNIVERSITY OF CHICAGO
- Current Assignee: THE UNIVERSITY OF CHICAGO
- Current Assignee Address: US IL Chicago
- Agency: Norton Rose Fulbright US LLP
- International Application: PCT/US2014/020896 WO 20140305
- International Announcement: WO2014/138298 WO 20140912
- Main IPC: A61K31/155
- IPC: A61K31/155 ; A61K31/136 ; A61K31/137 ; A61K31/225 ; A61K31/277 ; A61K31/4409 ; A61K38/21 ; A61K9/00 ; A61K38/03 ; A61K39/395 ; A61K45/06 ; A61K39/00
Abstract:
This invention discloses methods and compositions for the treatment of demyelinating disorders. Specifically, the invention relates to the use guanabenz or guanabenz derivative for treating demyelinating disorders.
Public/Granted literature
- US20160015659A1 TREATMENT OF DEMYELINATING DISORDERS Public/Granted day:2016-01-21
Information query
